Gait Training and Artificial Intelligence

November 23, 2025 updated by: Mohammed E. Ali, South Valley University

Gait Training in Above Knee Amputation Patients Using Artificial Intelligence

Effect of Using Artificial Intelligence on Gait Training in Above Knee Amputation Patients

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
    • Benha
      • Banhā, Benha, Egypt, 83523
        • Recruiting
        • Faculty of Physical Therapy,
        • Contact:
        • Contact:
        • Principal Investigator:
          • Mohammed E. Ali, PhD
        • Principal Investigator:
          • Nehad A. Abo-zaid, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All patients have above-knee amputations.
  • All patients have no other neurological diseases affecting gait.
  • All patients have no other neurological diseases affecting muscle balance.
  • All patients have no other complications affecting joint ROM.

Exclusion Criteria:

  • Patients have any complications affecting joint ROM.
  • Patients have any neurological condition affecting muscle balance.
  • Patients have any neurological condition affecting gait.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group A
Gait Training Using Artificial Intelligence
Device: Artificial Intelligence
using artificial intelligence in gait training for above knee amputee
No Intervention: group B
Traditional Physical Therapy Program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medio-lateral Stability Index (MLSI)
Time Frame: Day 0, Day 30
Medio-lateral Stability Index (MLSI) represents fluctuations from the horizontal around the mediolateral axis
Day 0, Day 30
Anterior-posterior Stability Index (APSI)
Time Frame: Day 0, Day 30
Anterior-posterior Stability Index (APSI) represents fluctuations from the horizontal around the anteroposterior axis
Day 0, Day 30
Overall Stability Index (OSI)
Time Frame: Day 0, Day 30
Overall Stability Index (OSI) a composite of MLSI and APSI so it is sensitive to changes in both directions
Day 0, Day 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

South Valley University

Collaborators

Benha University
Badr University
Al Salam University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2025

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

November 23, 2025

First Submitted That Met QC Criteria

November 23, 2025

First Posted (Estimated)

December 4, 2025

Study Record Updates

Last Update Posted (Estimated)

December 4, 2025

Last Update Submitted That Met QC Criteria

November 23, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • P.T.REC/012/004661

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on Artificial Intelligence

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe